Advertisement for orthosearch.org.uk
Results 201 - 220 of 421
Results per page:
Bone & Joint Research
Vol. 10, Issue 4 | Pages 237 - 249
1 Apr 2021
Chen X Chen W Aung ZM Han W Zhang Y Chai G

Aims

LY3023414 is a novel oral phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitor designed for advanced cancers, for which a phase II clinical study was completed in March 2020; however, little is known about its effect on bone modelling/remodelling. In this study, we aimed to explore the function of LY3023414 in bone modelling/remodelling.

Methods

The function of LY3023414 was explored in the context of osteogenesis (bone formation by osteoblasts) and osteoclastogenesis (osteoclast formation and bone resorption). Murine preosteoblast MC3T3-E1 cell line and murine bone marrow-derived macrophage cells (BMMs) were subjected to different treatments. An MTS cell proliferation assay was used to examine the cytotoxicity. Thereafter, different induction conditions were applied, such as MCSF and RANKL for osteoclastogenesis and osteogenic media for osteogenesis. Specific staining, a bone resorption assay, and quantitative real-time polymerase chain reaction (qRT-PCR) were subsequently used to evaluate the effect of LY3023414. Moreover, small interfering RNA (siRNA) was applied to knockdown Akt1 or Akt2 for further validation. Lastly, western blot was used to examine the exact mechanism of action.


Bone & Joint 360
Vol. 8, Issue 5 | Pages 4 - 10
1 Oct 2019
Tsoi K Samuel A Jeys LM Ashford RU Gregory JJ


The Journal of Bone & Joint Surgery British Volume
Vol. 94-B, Issue 9 | Pages 1277 - 1281
1 Sep 2012
Puri A Gulia A

Rarely, the extent of a malignant bone tumour may necessitate resection of the complete humerus to achieve adequate oncological clearance. We present our experience with reconstruction in such cases using a total humeral endoprosthesis (THER) in 20 patients (12 male and eight female) with a mean age of 22 years (6 to 59). We assessed the complications, the oncological and functional outcomes and implant survival. Surgery was performed between June 2001 and October 2009. The diagnosis included osteosarcoma in nine, Ewing’s sarcoma in eight and chondrosarcoma in three. One patient was lost to follow-up. The mean follow-up was 41 months (10 to 120) for all patients and 56 months (25 to 120) in survivors. There were five local recurrences (26.3%) and 11 patients were alive at time of last follow-up, with overall survival for all patients being 52% (95% confidence interval (CI) 23.8 to 74) at five years. The mean Musculoskeletal Tumor Society score for the survivors was 22 (73%; 16 to 23). The implant survival was 95% (95% CI 69.5 to 99.3) at five years. The use of a THER in the treatment of malignant tumours of bone is oncologically safe; it gives consistent and predictable results with low rates of complication


Bone & Joint 360
Vol. 8, Issue 5 | Pages 35 - 37
1 Oct 2019


Bone & Joint 360
Vol. 10, Issue 1 | Pages 19 - 24
1 Feb 2021


The Bone & Joint Journal
Vol. 102-B, Issue 4 | Pages 524 - 529
1 Apr 2020
Jamshidi K Mirkazemi M Gharedaghi M Izanloo A Mohammadpour M Pisoudeh K Bagherifard A Mirzaei A

Aims

The consensus is that bipolar hemiarthroplasty (BHA) in allograft-prosthesis composite (APC) reconstruction of the proximal femur following primary tumour resection provides more stability than total hip arthroplasty (THA). However, no comparative study has been performed. In this study, we have compared the outcome and complication rates of these two methods.

Methods

In a retrospective study, 57 patients who underwent APC reconstruction of proximal femur following the primary tumour resection, either using BHA (29) or THA (28), were included. Functional outcome was assessed using the Musculoskeletal Tumour Society (MSTS) scoring system and Harris Hip Score (HHS). Postoperative complications of the two techniques were also compared.


Bone & Joint Open
Vol. 1, Issue 6 | Pages 287 - 292
19 Jun 2020
Iliadis AD Eastwood DM Bayliss L Cooper M Gibson A Hargunani R Calder P

Introduction

In response to the COVID-19 pandemic, there was a rapidly implemented restructuring of UK healthcare services. The The Royal National Orthopaedic Hospital, Stanmore, became a central hub for the provision of trauma services for North Central/East London (NCEL) while providing a musculoskeletal tumour service for the south of England, the Midlands, and Wales and an urgent spinal service for London. This study reviews our paediatric practice over this period in order to share our experience and lessons learned. Our hospital admission pathways are described and the safety of surgical and interventional radiological procedures performed under general anaesthesia (GA) with regards to COVID-19 in a paediatric population are evaluated.

Methods

All paediatric patients (≤ 16 years) treated in our institution during the six-week peak period of the pandemic were included. Prospective data for all paediatric trauma and urgent elective admissions and retrospective data for all sarcoma admissions were collected. Telephone interviews were conducted with all patients and families to assess COVID-19 related morbidity at 14 days post-discharge.


Bone & Joint 360
Vol. 8, Issue 4 | Pages 42 - 44
1 Aug 2019


The Journal of Bone & Joint Surgery British Volume
Vol. 48-B, Issue 3 | Pages 488 - 492
1 Aug 1966
Jeffreys TE Stiles PJ

1. A case of pseudomalignant osseous tumour of soft tissue is reported. 2. The relationship between this condition and myositis ossificans is discussed and the importance of differentiating it from osteosarcoma is stressed


Bone & Joint 360
Vol. 8, Issue 6 | Pages 35 - 36
1 Dec 2019


Bone & Joint 360
Vol. 9, Issue 5 | Pages 41 - 43
1 Oct 2020


The Journal of Bone & Joint Surgery British Volume
Vol. 34-B, Issue 1 | Pages 93 - 96
1 Feb 1952
Cameron JAP Marsden ATH

A case is described of malignant osteoclastoma of the lower end of the femur in which death occurred from pulmonary metastases. The history was short and there was no interference with the primary growth, treatment being confined to disarticulation at the hip. Reasons are given for considering this neoplasm a malignant osteoclastoma rather than an osteogenic sarcoma, and the question of nomenclature is discussed


The Journal of Bone & Joint Surgery British Volume
Vol. 54-B, Issue 2 | Pages 334 - 340
1 May 1972
Chaplin DM Harrison MHM

1. Two cases of pseudomalignant osseous tumour of soft tissue are reported and added to the nineteen cases in the literature. 2. The clinical and histological features are described and distinguished from myositis ossificans, osteogenic sarcoma in soft tissue and parosteal fasciitis. 3. In one case the non-malignant nature of the lesion has been confirmed by its spontaneous regression


The Journal of Bone & Joint Surgery British Volume
Vol. 70-B, Issue 3 | Pages 354 - 357
1 May 1988
Pho R Patterson M Satku K

We describe a new method of reconstruction after resection of tumours of the proximal tibia by grafting and arthrodesis of the knee. Two separate vascularised bone grafts from the ipsilateral limb were used, one a gastrocnemius-pedicled femoral graft and the other a pedicled fibular graft. An anatomical study of the gastrocnemius-pedicled femoral graft was made. The method was shown to be practical and reproducible. One patient with osteosarcoma has a successful result with no recurrence at two-and-a-half years


The Journal of Bone & Joint Surgery British Volume
Vol. 52-B, Issue 2 | Pages 296 - 301
1 May 1970
Paterson DC

1. Four cases of myositis ossificans circumscripta are presented. 2. It remains an obscure condition but there are characteristic clinical, radiological and microscopical features. 3. While the majority of cases arise as a direct result of injury, these four cases suggest that this is not always so ; the diagnosis from osteosarcoma, bone or joint infection may then be difficult. 4. Noble's classification (1924) of myositis ossificans is adequate and should be accepted. Confusion would be avoided if cases such as those presented here were included in the classification suggested


The Bone & Joint Journal
Vol. 101-B, Issue 9 | Pages 1144 - 1150
1 Sep 2019
Tsuda Y Fujiwara T Sree D Stevenson JD Evans S Abudu A

Aims

The aim of this study was to report the results of custom-made endoprostheses with extracortical plates plus or minus a short, intramedullary stem aimed at preserving the physis after resection of bone sarcomas in children.

Patients and Methods

Between 2007 and 2017, 18 children aged less than 16 years old who underwent resection of bone sarcomas, leaving ≤ 5 cm of bone from the physis, and reconstruction with a custom-made endoprosthesis were reviewed. Median follow-up was 67 months (interquartile range 45 to 91). The tumours were located in the femur in 11 patients, proximal humerus in six, and proximal tibia in one.


The Bone & Joint Journal
Vol. 101-B, Issue 4 | Pages 484 - 490
1 Apr 2019
Nandra R Matharu G Stevenson J Parry M Grimer R Jeys L

Aims

The aim of this study was to investigate the local recurrence rate at an extended follow-up in patients following navigated resection of primary pelvic and sacral tumours.

Patients and Methods

This prospective cohort study comprised 23 consecutive patients (nine female, 14 male) who underwent resection of a primary pelvic or sacral tumour, using computer navigation, between 2010 and 2012. The mean age of the patients at the time of presentation was 51 years (10 to 77). The rates of local recurrence and mortality were calculated using the Kaplan–Meier method.


The Journal of Bone & Joint Surgery British Volume
Vol. 81-B, Issue 3 | Pages 495 - 500
1 May 1999
Ayoub KS Fiorenza F Grimer RJ Tillman RM Carter SR

We carried out extensible endoprosthetic replacement of the proximal or total humerus in 18 children aged between six and 12 years, after resection of primary bone tumours mainly for osteosarcoma and Ewing’s sarcoma. In 11 patients we performed 44 lengthening procedures, with an average of two per child annually and a mean total extension of 29.9 mm per patient. We were able to achieve lengthening of the operated limb with few complications and a mean functional rating of 79.3% according to the Enneking system. Progressive lengthening of these prostheses does not adversely affect the overall function of the arm, and superior subluxation of the head of the prosthesis has not been a problem


Bone & Joint 360
Vol. 8, Issue 3 | Pages 35 - 37
1 Jun 2019


The Bone & Joint Journal
Vol. 102-B, Issue 3 | Pages 280 - 284
1 Mar 2020
Ogura K Boland PJ Fabbri N Healey JH

Aims

Although internal hemipelvectomy is associated with a high incidence of morbidity, especially wound complications, few studies have examined rates of wound complications in these patients or have identified factors associated with the consequences. The present study aimed to: 1) determine the rate of wound and other complications requiring surgery after internal hemipelvectomy; and 2) identify factors that affect the rate of wound complications and can be used to stratify patients by risk of wound complications.

Methods

The medical records of 123 patients undergoing internal hemipelvectomy were retrospectively reviewed, with a focus on both overall complications and wound complications. Logistic regression analyses were performed to examine the association between host, tumour, and surgical factors and rates of postoperative wound complications.